Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Prenat Diagn ; 31(8): 821-6, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21692091

RESUMO

OBJECTIVE: To evaluate a 20% downward shift in the pregnancy-associated plasma protein A (PAPP-A) concentration on the test performance of first-trimester combined screening (FTS) for Down syndrome (DS) following a flaw in the production of PAPP-A kits on FTS for DS. METHODS: A retrospective re-evaluation of PAPP-A in stored sera. Inclusion criteria were a maternal weight-corrected PAPP-A multiple of the median value ≥ 0.9 and a biochemical risk of DS ≤ 1:200 at the time of testing. RESULTS: Of the 3100 women, 473 (15%) fulfilled the inclusion criteria. After combining the biochemical risk based on the incorrect PAPP-A values with nuchal translucency findings, an increased risk for DS was initially found in 107 women [false positive rate (FPR): 3.1]. Eighty-two (77%) of the 107 women opted for invasive testing. Following re-analysis of PAPP-A, the biochemical risk and the combined risk were statistically significantly different from the initial risk estimates (p < 0.001.). We noticed that 25 women (30%) had invasive testing, while this was unjustified given the re-analysed PAPP-A. CONCLUSION: Erroneous PAPP-A kits resulted in an increase in the FPR by 1.2%. There were no reports of iatrogenic miscarriage. The occurrence of this problem reaffirms the importance of continuous monitoring of quality in FTS.


Assuntos
Síndrome de Down/sangue , Programas de Rastreamento/normas , Proteína Plasmática A Associada à Gravidez/análise , Adulto , Biomarcadores/sangue , Feminino , Humanos , Pessoa de Meia-Idade , Gravidez , Primeiro Trimestre da Gravidez , Estudos Retrospectivos , Adulto Jovem
2.
Ned Tijdschr Geneeskd ; 148(44): 2166-71, 2004 Oct 30.
Artigo em Holandês | MEDLINE | ID: mdl-15559409

RESUMO

Prenatal investigations can be divided into specific diagnostic investigations i.e. chorionic villus sampling, amniocentesis and selective ultrasonography for the detection of fetal abnormality, and screening tests which estimate the chances of the condition being present. These include routine ultrasonography and tests based on biochemical and echoscopic markers. Amniocentesis is the most reliable test to detect chromosomal anomalies, but is associated with a low risk of miscarriage and the results are known only relatively late in pregnancy. Implementing the prenatal screening tests will enable the better identification of those women with an increased risk of chromosomal anomalies, and consequently to fewer invasive diagnostic procedures. The choice whether to have prenatal screening should always be made by the parents after they have been told of the advantages and disadvantages of these investigations.


Assuntos
Síndrome de Down/diagnóstico , Pais/psicologia , Diagnóstico Pré-Natal/métodos , Adulto , Amniocentese/métodos , Biomarcadores/análise , Biomarcadores/sangue , Amostra da Vilosidade Coriônica , Síndrome de Down/embriologia , Síndrome de Down/genética , Feminino , Humanos , Gravidez , Gravidez de Alto Risco , Diagnóstico Pré-Natal/efeitos adversos , Ultrassonografia Pré-Natal , alfa-Fetoproteínas/análise
3.
Prenat Diagn ; 23(8): 634-9, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12913869

RESUMO

OBJECTIVES: A retrospective analysis of the prognostic significance of the lung-to-head ratio (LHR) and other prenatal parameters on the outcome of fetuses with left-sided congenital diaphragmatic hernia (CDH). METHODS: A total of 26 fetuses with isolated left CDH without chromosomal abnormalities were included. Twenty-one LHR measurements could retrospectively be calculated from the last available ultrasonographic recordings before birth. The relationship between LHR and fetal outcome and the gestational age dependency of this relation was tested. Cutoff levels as previously published were applied to determine their predictive value in this population. The association between other prenatal predictive variables and fetal outcome was also determined. Survival was defined as discharge from the hospital. RESULTS: The overall survival rate was 50%. There was a statistically significant difference between the mean LHR of the survivors compared to the mean LHR of the nonsurvivors (1.78 vs 1.02), whereas the mean gestational age of these two groups did not differ. LHR was not gestational age dependent in the prediction of fetal outcome. The cutoff levels LHR <1, 1-1.4, >1.4 showed a good applicability in the prediction of fetal outcome within the present study population with a 100% survival if LHR >1.4 and a 100% mortality if LHR <1. An intrathoracic position of the stomach, mediastinal shift, polyhydramnios as individual variables and early diagnosis (<25 weeks' gestation) revealed to be poor sonographic predictors for fetal outcome. CONCLUSION: LHR proved to be a good predictor for fetal outcome, independent of gestational age at the time of the measurement. To substantiate our observation, a prospective multicenter study is warranted.


Assuntos
Cabeça/embriologia , Hérnias Diafragmáticas Congênitas , Pulmão/embriologia , Ultrassonografia Pré-Natal , Biometria , Cefalometria , Feminino , Idade Gestacional , Cabeça/diagnóstico por imagem , Hérnia Diafragmática/diagnóstico por imagem , Hérnia Diafragmática/mortalidade , Humanos , Pulmão/diagnóstico por imagem , Poli-Hidrâmnios/complicações , Gravidez , Prognóstico , Estômago , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...